Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 2 of 2
- New Global Survey by Johnson & Johnson Finds Most Women Don’t Connect Eye Health Changes with Menopause
- 10/1/2026 1:25:20 PM
- Johnson & Johnson (NYSE: JNJ) today released new findings that show most women know menopause can affect mood and sleep, but fewer than half realize their eye health may change too.
- Study Links 90+-Day Spaceflights to Higher Rates of Hip Fractures in Astronauts
- 10/1/2026 12:39:02 PM
- New research has found that the rate of hip fractures in astronauts back on Earth was greater in the time period after an astronaut has been in space for more than 90 days than in the time period following shorter spaceflights or in non-astronauts.
- Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies
- 10/1/2026 11:59:27 AM
- • REGN20423, a clinical-stage long-acting IL-13 monoclonal antibody invented and developed by Regeneron, is added to the Alliance, along with a long-acting IL-4xIL-13 bispecific and two other long-acting pre-clinical antibodies from Regeneron • Regeneron to receive $1 billion upfront, with potential for up to an additional $7 billion in future milestone payments; …
- Elsevier launches ClinicalKey Nursing AI, a new evidenced-based clinical AI solution built specifically for nurses
- 9/30/2026 9:42:54 AM
- Elsevier announced the global launch of ClinicalKey Nursing AI, the clinical AI tool built specifically for nurses and designed to support both point of care decision-making and professional growth across the nursing career journey.
- Arvato Systems Runs European Medicines Verification System on Oracle EU Sovereign Cloud
- 9/22/2026 7:50:11 AM
- Arvato Systems, a global IT and multicloud services provider, is using Oracle EU Sovereign Cloud to support prescription medicine verification across 15 European countries.
- Can vitamin C improve outcomes in people with pre-cancer blood disorders?
- 9/21/2026 9:58:10 AM
- Vitamin C boosts the activity of cellular proteins called TET enzymes that help control which genes are turned on or off. Because decreased function of TET enzymes is a common driver of certain forms of blood cancer, researchers tested the effects of vitamin C supplements in patients at risk of developing such malignancies.
- Telehealth and Medicine Today Announces 2025 Research Article Award Recipients
- 9/21/2026 8:30:00 AM
- Telehealth and Medicine Today (THMT), an international peer reviewed journal advancing telehealth, digital health and medical innovation, today announced the recipients of its 2025 research article honors.
- « Previous
- 1
- 2
- Next »